(6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド
(6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド 物理性質
- 融点 :
- 225°C
- 沸点 :
- 609℃
- 比重(密度) :
- 1.698
- 闪点 :
- 322℃
- 溶解性:
- soluble in Methanol, Water
(6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド 価格
もっと(7)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQC-1751 |
6-Bromo-2-naphthyl-alpha-d-galactopyranoside |
25997-59-5 |
250mg |
¥80000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQC-1751 |
6-ブロモ-2-ナフチル-α-D-Galアクトピラノシド
6-Bromo-2-naphthyl-alpha-d-galactopyranoside |
25997-59-5 |
1g |
¥200000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQC-1751 |
6-ブロモ-2-ナフチル-α-D-Galアクトピラノシド
6-Bromo-2-naphthyl-alpha-d-galactopyranoside |
25997-59-5 |
500mg |
¥90000 |
2021-03-23 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCB685975 |
6-Bromo-2-naphthyl-α-D-galactopyranoside |
25997-59-5 |
100mg |
¥53900 |
2023-06-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TRCB685975 |
6-Bromo-2-naphthyl-α-D-galactopyranoside |
25997-59-5 |
1g |
¥421600 |
2023-06-01 |
購入 |
(6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド 化学特性,用途語,生産方法
使用
6-Bromo-2-naphthyl α-D-galactopyranoside can be acted as a useful reagent for determination of alpha-D-Galactosidase activity.
定義
ChEBI: An alpha-D-galactoside having a 6-bromo-2-naphthyl substituent at the anomeric position.
純化方法
It is prepared from penta-O-acetyl-D-galactoside, 6-bromo-2naphthol and ZnCl2. The resulting tetra-acetate (2g) is hydrolysed by dissolving in 0.3N KOH (100mL) and heating until the solution is clear, then filtering and cooling to give colourless crystals of the -isomer which are collected and recrystallised twice from hot MeOH. The high specific rotation is characteristic of the isomer. The tetraacetate has m 155-156o, [] D 20 +60o (c 1, CHCl3) [Dey & Pridham Biochem J 115 47 1969] [reported m 75-85o, [] D 24 +94o (c 1.3, dioxane), Monis et al. J Histochem Cytochem 11 653 1963]. [Beilstein 17 IV 2972.]
(6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド 上流と下流の製品情報
原材料
準備製品
(6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド 生産企業
Global( 52)Suppliers
25997-59-5((6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド)キーワード:
- 25997-59-5
- 6-BROMO NAPHTHYL GALACTOPYRANOSIDE
- 6-BROMO-2-NAPHTHYL-A-D-GALACTOPYRANOSIDE
- 6-BROMO-2-NAPHTHYL-ALPHA-D-GALACTOPYRANOSIDE
- 2-(6-BROMONAPHTHYL)-ALPHA-D-GALACTOPYRANOSIDE
- BR-NAP-ALPHA-D-GAL
- BROMO-2-NAPHTHYL-A-D-GALACTOPYRANOSIDE, 6-
- 6-Bromo-2-Naphthyl-Alpha-D-Galactopyran-
- (6-Bromo-2-naphthalenyl)α-D-galactopyranoside
- (2R,3R,4S,5R,6R)-2-(6-bromonaphthalen-2-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5R,6R)-2-[(6-bromo-2-naphthyl)oxy]-6-methylol-tetrahydropyran-3,4,5-triol
- BROMO-2-NAPHTHYL-a-D-GALACTOPYRANOSIDE, 6-(RG)
- 6-Bromo-2-naphthyl alpha-D-galactoside
- alpha-D-6-Bromo-2-naphthylgalactopyranoside
- 6-Bromo-2-naphthyl-α-D-galactopyranoside
- 6-Bromo-2-naphthyl α-D-galactopyranoside USP/EP/BP
- (2R,3R,4S,5R,6R)-2-((6-bromonaphthalen-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- 6-ブロモ-2-ナフチルα-D-ガラクトピラノシド
- (6-ブロモ-2-ナフタレニル)α-D-ガラクトピラノシド
- 6-ブロモ-2-ナフチル-Α-D-GALアクトピラノシド
- 6-ブロモ-2-ナフチル-Α-D-ガラクトピラノシド
- (2R,3R,4S,5R,6R)-2-[(6-ブロモナフタレン-2-イル)オキシ]-6-(ヒドロキシメチル)オキサン-3,4,5-トリオール